| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 33.61 | 1-year : | 39.26 |
| Resists | First : | 28.78 | Second : | 33.61 |
| Pivot price | 26.54  |
|||
| Supports | First : | 25.86 | Second : | 24.06 |
| MAs | MA(5) : | 27.22  |
MA(20) : | 26.43 |
| MA(100) : | 31.11 |
MA(250) : | 38.86 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 60.7 |
D(3) : | 66.9 |
| RSI | RSI(14): 47.4 |
|||
| 52-week | High : | 55.33 | Low : | 24.06 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TWST ] has closed below upper band by 41.7%. Bollinger Bands are 38.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.07 - 27.25 | 27.25 - 27.41 |
| Low: | 25.9 - 26.12 | 26.12 - 26.33 |
| Close: | 26.55 - 26.92 | 26.92 - 27.24 |
Wed, 24 Sep 2025
Twist Bioscience (NASDAQ:TWST) CEO Sells $46,962.24 in Stock - MarketBeat
Wed, 24 Sep 2025
Dennis Cho sells Twist Bioscience (TWST) shares for $6,421 - Investing.com
Tue, 23 Sep 2025
A Look at Twist Bioscience’s Valuation After Management Highlights Profit Milestones and Growth Plans at 2025 Conference - Sahm
Tue, 23 Sep 2025
Strs Ohio Buys Shares of 18,100 Twist Bioscience Corporation $TWST - MarketBeat
Sun, 21 Sep 2025
Can Twist Bioscience’s (TWST) Path to Profitability Reshape Its Competitive Position in Synthetic Biology? - simplywall.st
Fri, 19 Sep 2025
Interesting TWST Put And Call Options For November 21st - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 60 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 1.8 (%) |
| Held by Institutions | 115.9 (%) |
| Shares Short | 10,230 (K) |
| Shares Short P.Month | 10,440 (K) |
| EPS | -1.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.94 |
| Profit Margin | -23.6 % |
| Operating Margin | -31.4 % |
| Return on Assets (ttm) | -13.9 % |
| Return on Equity (ttm) | -17.6 % |
| Qtrly Rev. Growth | 17.8 % |
| Gross Profit (p.s.) | 2.95 |
| Sales Per Share | 6 |
| EBITDA (p.s.) | -1.98 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -51 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -18.69 |
| PEG Ratio | 0 |
| Price to Book value | 3.38 |
| Price to Sales | 4.48 |
| Price to Cash Flow | -31.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|